Home About us Contact
|
Home About us Contact | ||
|
|
||
Multifunctional Growth Factor (multifunctional + growth_factor)
Selected AbstractsActivation of hepatocyte growth factor activator zymogen (pro-HGFA) by human kallikrein 1-related peptidasesFEBS JOURNAL, Issue 5 2008Shoichiro Mukai Hepatocyte growth factor activator (HGFA) is a serine protease and a potent activator of prohepatocyte growth factor/scatter factor (pro-HGF/SF), a multifunctional growth factor that is critically involved in tissue morphogenesis, regeneration, and tumor progression. HGFA circulates as a zymogen (pro-HGFA) and is activated in response to tissue injury. Although thrombin is considered to be an activator of pro-HGFA, alternative pro-HGFA activation pathways in tumor microenvironments remain to be identified. In this study, we examined the effects of kallikrein 1-related peptidases (KLKs), a family of extracellular serine proteases, on the activation of pro-HGFA. Among the KLKs examined (KLK2, KLK3, KLK4 and KLK5), we identified KLK4 and KLK5 as novel activators of pro-HGFA. Using N-terminal sequencing, the cleavage site was identified as the normal processing site, Arg407,Ile408. The activation of pro-HGFA by KLK5 required a negatively charged substance such as dextran sulfate, whereas KLK4 could process pro-HGFA without dextran sulfate. KLK5 showed more efficient pro-HGFA processing than KLK4, and was expressed in 50% (13/25) of the tumor cell lines examined. HGFA processed by these KLKs efficiently activated pro-HGF/SF, and led to cellular scattering and invasion in vitro. The activities of both KLK4 and KLK5 were strongly inhibited by HGFA inhibitor type 1, an integral membrane Kunitz-type serine protease inhibitor that inhibits HGFA and other pro-HGF/SF-activating proteases. These data suggest that KLK4 and KLK5 mediate HGFA-induced activation of pro-HGF/SF within tumor tissue, which may thereafter trigger a series of events leading to tumor progression via the MET receptor. [source] Generation of mice with a conditional allele for transforming growth factor beta 1 geneGENESIS: THE JOURNAL OF GENETICS AND DEVELOPMENT, Issue 6 2009Mohamad Azhar Abstract Transforming growth factor ,1 (TGF,1) is a multifunctional growth factor involved in wound healing, tissue fibrosis, and in the pathogenesis of many syndromic diseases (e.g., Marfan syndrome, Camurati-Engelmann disease) and muscular, neurological, ophthalmic, cardiovascular and immunological disorders, and cancer. Since the generation of Tgfb1 knockout mice, there has been extraordinary progress in understanding its physiological and pathophysiological function. Here, we report the generation of a conditional knockout allele for Tgfb1 in which its exon 6 is flanked with LoxP sites. As proof of principle, we crossed these mice to LckCre transgenic mice and specifically disrupted Tgfb1 in T cells. The results indicate that T-cell-produced TGF,1 is required for normal in vivo regulation of peripheral T-cell activation, maintenance of T-cell homeostasis, and suppression of autoimmunity. genesis 47:423,431, 2009. © 2009 Wiley-Liss, Inc. [source] TGF-, inhibits prolactin-induced expression of ,-casein by a Smad3-dependent mechanism,JOURNAL OF CELLULAR BIOCHEMISTRY, Issue 5 2008Wen-Jun Wu Abstract Transforming growth factor-, (TGF-,) is a multifunctional growth factor, affecting cell proliferation, apoptosis, and extracellular matrix homeostasis. It also plays critical roles in mammary gland development, one of which involves inhibition of the expression of milk proteins, such as ,-casein, during pregnancy. Here we further explore the underlying signaling mechanism for it. Our results show that TGF-, suppresses prolactin-induced expression of ,-casein mRNA and protein in primary mouse mammary epithelial cells, but its effect on protein expression is more evident. We also find out that this inhibition is not due to the effect of TGF-, on cell apoptosis. Furthermore, inhibition of TGF-, type I receptor kinase activity by a pharmacological inhibitor SB431542 or overexpression of dominant negative Smad3 substantially restores ,-casein expression. By contrast, inhibition of p38 and Erk that are known to be activated by TGF-, does not alleviate the inhibitory effect of TGF-,. These results are consistent with our other observation that Smad but not MAPK pathway is activated by TGF-, in mammary epithelial cells. Lastly, we show that prolactin-induced tyrosine phosphorylation of Jak2 and Stat5 as well as serine/threonine phosphorylation of p70S6K and S6 ribosomal protein are downregulated by TGF-,, although the former event requires considerably long exposure to TGF-,. We speculate that these events might be involved in repressing transcription and translation of ,-casein gene, respectively. Taken together, our results demonstrate that TGF-, abrogates prolactin-stimulated ,-casein gene expression in mammary epithelial cells through, at least in part, a Smad3-dependent mechanism. J. Cell. Biochem. 104: 1647,1659, 2008. © 2008 Wiley-Liss, Inc. [source] Transforming growth factor-,2 modulates synaptic efficacy and plasticity and induces phosphorylation of CREB in hippocampal neuronsHIPPOCAMPUS, Issue 1 2007Teruyuki Fukushima Abstract Transforming growth factor-,s (TGF-,s) are widely expressed and play roles as multifunctional growth factors and regulators of key events in development, disease, and repair. However, it is not known whether TGF-,s affect the plasticity of hippocampal neurons. As a first step to address this issue, we examined whether TGF-,2 modulated the electrophysiological and biochemical properties of cultured hippocampal neurons. We found that prolonged 24 h treatment with TGF-,2 induced facilitation of evoked postsynaptic currents (ePSCs). This facilitation was associated with a decrease in short-term synaptic depression of ePSCs and increases in both the amplitude and frequency of spontaneous miniature postsynaptic currents (mPSCs). The long-term changes of ePSCs and mPSCs may be associated with cAMP response element-binding protein (CREB), which has been previously implicated in long-term potentiation. Immunofluorescence techniques and Western blot analysis both revealed that TGF-,2 enhanced the phosphorylation of CREB. Together, these results suggest that TGF-,2 may play a role in the cascade of events underlying long-term synaptic facilitation in hippocampus, and that CREB may be an important mediator of these effects. © 2006 Wiley-Liss, Inc. [source] BMP inhibition enhances axonal growth and functional recovery after spinal cord injuryJOURNAL OF NEUROCHEMISTRY, Issue 4 2008Iichiro Matsuura Abstract Bone morphogenetic proteins (BMPs) are multifunctional growth factors that belong to the transforming growth factor-, superfamily. BMPs regulate several crucial aspects of embryonic development and organogenesis. The reemergence of BMPs in the injured adult CNS suggests their involvement in the pathogenesis of the lesion. Here, we demonstrate that BMPs are potent inhibitors of axonal regeneration in the adult spinal cord. The expression of BMP-2/4 is elevated in oligodendrocytes and astrocytes around the injury site following spinal cord contusion. Intrathecal administration of noggin , a soluble BMP antagonist,leads to enhanced locomotor activity and reveals significant regrowth of the corticospinal tract after spinal cord contusion. Thus, BMPs play a role in inhibiting axonal regeneration and limiting functional recovery following injury to the CNS. [source] | ||||||||||